The High Throughput Screening (HTS) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the High Throughput Screening (HTS) Market?
The market size of the high throughput screening (HTS) has seen considerable growth recently. It is anticipated to increase from $22.98 billion in 2024 to $25.49 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the High Throughput Screening (HTS) Industry?
The High Throughput Screening (HTS) Global Market Report forecasts that by 2029, the market size is expected to reach $36 billion, growing at a compound annual growth rate (CAGR) of 9.0%.
Download Your Free Sample of the 2025 High Throughput Screening (HTS) Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the High Throughput Screening (HTS) Market?
The key drivers in the high throughput screening (hts) market are:
• Strategic developments by key players in the market
• Increasing demand for disease monitoring and drug discovery solutions
• Rising prevalence of chronic diseases globally
• Growing focus towards the implementation of ultra high throughput screening (UHTS) techniques.
Global Market Segmentation: Identifying Major High Throughput Screening (HTS) Industry Segments
The high throughput screening (HTS) market covered in this report is segmented –
1) By Products And Services: Consumables And Reagents, Instruments, Software And Services
2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology
3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications
4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users
Pre-order the 2025 High Throughput Screening (HTS) Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the High Throughput Screening (HTS) Market?
The key trends in the high throughput screening (hts) market are:
• Technological advancements in high-throughput screening are predicted to play a major role in the market.
• The demand for disease monitoring and drug discovery is rising, influencing the HTS market.
• Increasing cases of chronic diseases is seen as an important trend for the HTS market.
• The implementation of ultra-high throughput screening (UHTS) techniques is an emerging trend.
Who Are the Top Competitors & Leading Players in the High Throughput Screening (HTS) Market?
Major companies in the high throughput screening (hts) market are:
• Thermo Fisher Scientific Inc.
• AstraZeneca Plc
• Danaher Corporation
• Merck Group
• GE HealthCare Technologies Inc.
• Corning Inc.
• Agilent Technologies Inc.
• Lonza Group Ltd.
• Charles River Laboratories International Inc
• Beckman Coulter Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories
• Tecan Group Ltd.
• Sygnature Discovery Ltd.
• Luminex Corporation
• Hamilton Company
• Crown Bioscience Inc.
• HighRes Biosolutions
• NanoTemper Technologies GmbH
• BMG LABTECH GmbH
• Axxam SpA
• Reprocell Inc.
• BioTek Instruments Inc
• Aurora Biomed Inc.
• Cyclica Inc.
• Biomat Srl
• Diana Biotechnologies s.r.o
Regional Dominance: Which Area Leads the Global High Throughput Screening (HTS) Market?
North America was the largest region in the high throughput screening market in 2024
